Moving Drug Candidates to Clinical Trials Faster

Symyx Technologies has launched the Symyx Contract Development and Manufacturing Organisation (CDMO).

CDMO helps biopharmaceutical companies to move promising drug candidates to clinical trials faster and more reliably with integrated formulation development, and preclinical and current good manufacturing practice (cGMP) fill/finish manufacturing.

It enables faster development of optimized and robust drug formulations, so that clinical trials test the efficacy of drug candidates, not the limitations of the formulation.

It offers full service fill/finish execution for delivering drug products manufactured under CGMP conditions while maintaining the integrity of drug substances and meeting preclinical and Phase I and II clinical trial schedules.